Intravitreal bevacizumab in a patient with a macular star in malignant hypertension

Ilaria Zucchiatti; Pierluigi Iacono; Maurizio Battaglia Parodi; Maria Lucia Cascavilla; Dimitris Stelios Kontadakis; Francesco Bandello

doi:10.5301/EJO.2010.5819

Intravitreal bevacizumab in a patient with a macular star in malignant hypertension

Ilaria Zucchiatti, Pierluigi Iacono, Maurizio Battaglia Parodi, Maria Lucia Cascavilla, Dimitris Stelios Kontadakis, Francesco Bandello

Research output: Contribution to journal › Article › peer-review

Abstract

Purpose. To report a case of retinopathy secondary to malignant hypertension showing a macular star, which responded favorably to a single intravitreal injection of bevacizumab (IVB). Methods. A 46-year-old man with malignant hypertension showing incomplete macular star in his right eye with best-corrected visual acuity (BCVA) of 20/32 underwent IVB. Results. Subsequent examinations revealed a progressive resolution of the macular star with functional recovery over the follow-up. In particular, at the 9-month examination BCVA was 20/20, fundus bio-microscopy disclosed resolution of the macular star, and the retinal sensitivity improved remarkably. Conclusions. Intravitreal injection of bevacizumab can be a useful approach to treat the exudative manifestations of malignant hypertension.

Original language	English
Pages (from-to)	336-339
Number of pages	4
Journal	European Journal of Ophthalmology
Volume	21
Issue number	3
DOIs	https://doi.org/10.5301/EJO.2010.5819
Publication status	Published - May 2011

Keywords

Intravitreal bevacizumab
Malignant hypertension
Vascular endothelial growth factor

ASJC Scopus subject areas

Ophthalmology

Access to Document

10.5301/EJO.2010.5819

Cite this

@article{db138686ebe944dd82756eb9fb731ee4,

title = "Intravitreal bevacizumab in a patient with a macular star in malignant hypertension",

abstract = "Purpose. To report a case of retinopathy secondary to malignant hypertension showing a macular star, which responded favorably to a single intravitreal injection of bevacizumab (IVB). Methods. A 46-year-old man with malignant hypertension showing incomplete macular star in his right eye with best-corrected visual acuity (BCVA) of 20/32 underwent IVB. Results. Subsequent examinations revealed a progressive resolution of the macular star with functional recovery over the follow-up. In particular, at the 9-month examination BCVA was 20/20, fundus bio-microscopy disclosed resolution of the macular star, and the retinal sensitivity improved remarkably. Conclusions. Intravitreal injection of bevacizumab can be a useful approach to treat the exudative manifestations of malignant hypertension.",

keywords = "Intravitreal bevacizumab, Malignant hypertension, Vascular endothelial growth factor",

author = "Ilaria Zucchiatti and Pierluigi Iacono and Parodi, {Maurizio Battaglia} and Cascavilla, {Maria Lucia} and Kontadakis, {Dimitris Stelios} and Francesco Bandello",

year = "2011",

month = may,

doi = "10.5301/EJO.2010.5819",

language = "English",

volume = "21",

pages = "336--339",

journal = "European Journal of Ophthalmology",

issn = "1120-6721",

publisher = "Wichtig Publishing",

number = "3",

}

TY - JOUR

T1 - Intravitreal bevacizumab in a patient with a macular star in malignant hypertension

AU - Zucchiatti, Ilaria

AU - Iacono, Pierluigi

AU - Parodi, Maurizio Battaglia

AU - Cascavilla, Maria Lucia

AU - Kontadakis, Dimitris Stelios

AU - Bandello, Francesco

PY - 2011/5

Y1 - 2011/5

N2 - Purpose. To report a case of retinopathy secondary to malignant hypertension showing a macular star, which responded favorably to a single intravitreal injection of bevacizumab (IVB). Methods. A 46-year-old man with malignant hypertension showing incomplete macular star in his right eye with best-corrected visual acuity (BCVA) of 20/32 underwent IVB. Results. Subsequent examinations revealed a progressive resolution of the macular star with functional recovery over the follow-up. In particular, at the 9-month examination BCVA was 20/20, fundus bio-microscopy disclosed resolution of the macular star, and the retinal sensitivity improved remarkably. Conclusions. Intravitreal injection of bevacizumab can be a useful approach to treat the exudative manifestations of malignant hypertension.

AB - Purpose. To report a case of retinopathy secondary to malignant hypertension showing a macular star, which responded favorably to a single intravitreal injection of bevacizumab (IVB). Methods. A 46-year-old man with malignant hypertension showing incomplete macular star in his right eye with best-corrected visual acuity (BCVA) of 20/32 underwent IVB. Results. Subsequent examinations revealed a progressive resolution of the macular star with functional recovery over the follow-up. In particular, at the 9-month examination BCVA was 20/20, fundus bio-microscopy disclosed resolution of the macular star, and the retinal sensitivity improved remarkably. Conclusions. Intravitreal injection of bevacizumab can be a useful approach to treat the exudative manifestations of malignant hypertension.

KW - Intravitreal bevacizumab

KW - Malignant hypertension

KW - Vascular endothelial growth factor

UR - http://www.scopus.com/inward/record.url?scp=79953663139&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953663139&partnerID=8YFLogxK

U2 - 10.5301/EJO.2010.5819

DO - 10.5301/EJO.2010.5819

M3 - Article

C2 - 20954147

AN - SCOPUS:79953663139

VL - 21

SP - 336

EP - 339

JO - European Journal of Ophthalmology

JF - European Journal of Ophthalmology

SN - 1120-6721

IS - 3

ER -

Intravitreal bevacizumab in a patient with a macular star in malignant hypertension

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this